The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group
Open accessAbstract
A Task Force was established by the International Restless Legs Syndrome Study Group (IRLSSG) to develop evidence-based and consensus-based recommendations for the long-term pharmacologic treatment of restless legs syndrome/Willis-Ekbom disease (RLS/WED). The Task Force reviewed the results of all studies of RLS/WED treatments with durations of 6 months or longer presented at meetings over the past 2 years, posted on Web sites of pharmaceutical companies, or published in peer-reviewed journals, asking the questions, "What is the efficacy of this treatment in patients with RLS/WED?" and "What is the safety of this treatment in patients with RLS/WED?" The Task Force developed guidelines based on their review of 61 papers meeting inclusion criteria, and using a modified evidence-grading scheme. Pregabalin has been established as effective for up to 1 year in treating RLS/WED (Level A evidence). Pramipexole, ropinirole, and rotigotine have been established as effective for up to 6 months in treating RLS/WED (Level A). The following drugs have been established as probably effective (Level B) in treating RLS/WED for durations ranging from 1 to 5 years: gabapentin enacarbil, pramipexole, and ropinirole (1 year); levodopa (2 years); and rotigotine (5 years). Because of associated safety concerns, pergolide and cabergoline should not be used in the treatment of RLS/WED unless the benefits clearly outweigh the risks. Other pharmacologic therapies have insufficient evidence to support their long-term use in treating RLS/WED. The IRLSSG Task Force also developed consensus-based strategies for the prevention and treatment of complications (such as augmentation, loss of efficacy, excessive daytime sleepiness, and impulse control disorders) that may develop with the long-term pharmacologic treatment of RLS/WED. The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLS/WED symptoms, cognitive status, history, and comorbid conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology
Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisi, J. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00010-8 · Cited by 2,900
Self-citationSystems to rate the strength of scientific evidence.
West, S. L., King, V., Carey, T. S., Lohr, K. N., Mckoy, N. A., Sutton, S. F., & Lux, L. J. (2002) · PubMed · Cited by 885
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 718
Brainin, M., Barnes, M., Baron, J. ‐., Gilhus, N. E., Hughes, R., Selmaj, K., & Waldemar, G. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00867.x · Cited by 375
An American Academy of Sleep Medicine Review
Sateia, M. J., Doghramji, K., Hauri, P., & Morin, C. M. (2000) · Cited by 370
The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
(1999) · Sleep · doi:10.1093/sleep/22.7.970 · Cited by 322
A questionnaire study of 138 patients with restless legs syndrome: The `Night-Walkers' survey
Walters, A. S., Hickey, K., Maltzman, J., Verrico, T., Joseph, D., Hening, W., Wilson, V., & Chokroverty, S. (1996) · Neurology · doi:10.1212/wnl.46.1.92 · Cited by 319
An Algorithm for the Management of Restless Legs Syndrome
Silber, M. H., Ehrenberg, B. L., Allen, R. P., Buchfuhrer, M. J., Earley, C. J., Hening, W. A., & Rye, D. B. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.7.916 · Cited by 300
Self-citationSchenck, C. H., & Mahowald, M. W. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89493-4 · Cited by 291
Practice Parameters for the Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
Chesson, A. L., Wise, M., Davila, D., Johnson, S., Littner, M., Anderson, W. M., Hartse, K., & Rafecas, J. (1999) · Sleep · doi:10.1093/sleep/22.7.961 · Cited by 287
Cited by
Allen, R. P., Picchietti, D. L., Garcia-Borreguero, D., Ondo, W. G., Walters, A. S., Winkelman, J. W., Zucconi, M., Ferri, R., Trenkwalder, C., & Lee, H. B. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.03.025 · Cited by 1,609
Self-citationZamponi, G. W., Striessnig, J., Koschak, A., & Dolphin, A. C. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009654 · Cited by 1,103
Allen, R. P., Picchietti, D. L., Auerbach, M., Cho, Y. W., Connor, J. R., Earley, C. J., Garcia-Borreguero, D., Kotagal, S., Manconi, M., Ondo, W., et al. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2017.11.1126 · Cited by 349
Self-citationGarcia-Borreguero, D., Silber, M. H., Winkelman, J. W., Högl, B., Bainbridge, J., Buchfuhrer, M., Hadjigeorgiou, G., Inoue, Y., Manconi, M., Oertel, W., et al. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.01.017 · Cited by 342
Self-citationSleep Disturbances in Frontotemporal Dementia
McCarter, S. J., St. Louis, E. K., & Boeve, B. F. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0680-3 · Cited by 80
Metadata
- Authors
- Garcia-Borreguero, D., Kohnen, R., Silber, M. H., Winkelman, J. W., Earley, C. J., Högl, B., Manconi, M., Montplaisir, J., Inoue, Y., & Allen, R. P.
- Venue
- Sleep Medicine
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 14
- Issue
- 7
- Pages
- 675-684
- ISSN
- 1389-9457 (ISSN-L)
- OpenAlex
- W2139927499
- Cited by
- 291
- References
- 67
- FWCI
- 27.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. https://app.cochat.ai/papers/10.1016/j.sleep.2013.05.016
- The paper
- Garcia-Borreguero, D., Kohnen, R., Silber, M. H., Winkelman, J. W., Earley, C. J., Högl, B., Manconi, M., Montplaisir, J., Inoue, Y., & Allen, R. P. (2013). The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Medicine. https://doi.org/10.1016/j.sleep.2013.05.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.